Jagadeesh Aluri
About
Jagadeesh Aluri is a scholar working on Molecular Biology, Pharmacology and Cognitive Neuroscience.
According to data from OpenAlex, Jagadeesh Aluri has authored 50 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Cognitive Neuroscience. Recurrent topics in Jagadeesh Aluri's work include Sleep and related disorders (10 papers), Sleep and Wakefulness Research (10 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Jagadeesh Aluri is often cited by papers focused on Sleep and related disorders (10 papers), Sleep and Wakefulness Research (10 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Jagadeesh Aluri collaborates with scholars based in United States, United Kingdom and Japan. Jagadeesh Aluri's co-authors include Jean Fan, Robert Shumaker, Min Ren, Margaret Moline, Gary A. Thompson, Nancy Hall, Ishani Landry, Jim Ferry, Min Ren and Bhaskar Rege and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.
In The Last Decade
Jagadeesh Aluri
47 papers receiving 616 citations
Peers
Jagadeesh Aluri
Priska Kaufmann Switzerland
S. Erill Spain
James Hilbert United States
Nancy Agrawal United States
Sarah R. Bujac United Kingdom
Peter Zannikos United States
Amanda Darekar United Kingdom
Peter Neubert United States
Patricia N. Sidharta Switzerland
S. Leigh Verbois United States
Citations per year, relative to Jagadeesh Aluri Jagadeesh Aluri (= 1×)
peers
Priska Kaufmann
Countries citing papers authored by Jagadeesh Aluri
Since
Specialization
Citations
This map shows the geographic impact of Jagadeesh Aluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagadeesh Aluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagadeesh Aluri more than expected).
Fields of papers citing papers by Jagadeesh Aluri
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jagadeesh Aluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagadeesh Aluri. The network helps show where Jagadeesh Aluri may publish in the future.
Co-authorship network of co-authors of Jagadeesh Aluri
This figure shows the co-authorship network connecting the top 25 collaborators of Jagadeesh Aluri. A scholar is included among the top collaborators of Jagadeesh Aluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagadeesh Aluri. Jagadeesh Aluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Majid, Oneeb, Seiichi Hayato, Bojan Lalovic, et al.. (2024). Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC). CPT Pharmacometrics & Systems Pharmacology. 13(6). 954–969.
2.
Rawal, Sumit, et al.. (2023). Lemborexant levels in breast milk after single doses in healthy, lactating women. British Journal of Clinical Pharmacology. 90(1). 158–163.
3.
Landry, Ishani, Nancy Hall, Jagadeesh Aluri, et al.. (2022). Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study. Journal of Psychopharmacology. 36(6). 745–755.
4.
Landry, Ishani, et al.. (2022). E2027 Cardiac Safety Evaluation With Concentration-Response Modeling of ECG Data to Inform Dose Selection in Studies in Patients With Dementia With Lewy Bodies. Alzheimer Disease & Associated Disorders. 36(3). 208–214.
5.
Hussein, Ziad, Oneeb Majid, Peter D. W. Boyd, et al.. (2022). Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study. Clinical Pharmacology in Drug Development. 11(7). 878–888.
6.
Nakai, Kenya, Yasumi Kitahara, Seiichiro Hojo, et al.. (2022). First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers. Clinical Pharmacology in Drug Development. 12(4). 363–375.
7.
Landry, Ishani, Jagadeesh Aluri, Nancy Hall, et al.. (2021). Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females. Clinical Pharmacology in Drug Development. 10(9). 1089–1098.
8.
Shumaker, Robert, et al.. (2020). An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Patients with Advanced Solid Tumors. European Journal of Drug Metabolism and Pharmacokinetics. 45(3). 373–383.
9.
Cruz, Filemon S. Dela, Elizabeth Fox, Jodi A. Muscal, et al.. (2020). A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.. Journal of Clinical Oncology. 38(15_suppl). 10527–10527.
10.
Ueno, Takashi, T. Ishida, Jagadeesh Aluri, et al.. (2020). Disposition and Metabolism of [14C]Lemborexant in Healthy Human Subjects and Characterization of Its Circulating Metabolites. Drug Metabolism and Disposition. 49(1). 31–38.
11.
Landry, Ishani, Jagadeesh Aluri, Nancy Hall, et al.. (2020). Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant. Pharmacology Research & Perspectives. 8(6). e00678–e00678.
12.
Nakai, Kenya, Sanae Yasuda, Mark Matijevic, et al.. (2018). Safety, pharmacokinetics, and pharmacodynamics in first-in-human study of a novel compound E6742, a Toll-like receptor 7 and 8 antagonist. Proceedings for Annual Meeting of The Japanese Pharmacological Society. WCP2018(0). PO1–11.
13.
Landry, Ishani, Robert Lai, Peter D. W. Boyd, et al.. (2018). P1‐055: E2027, A NOVEL PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR IN DEVELOPMENT FOR TREATMENT OF DEMENTIA WITH LEWY BODIES (DLB), SHOWED NO CLINICALLY SIGNIFICANT DRUG INTERACTION WITH DILTIAZEM. Alzheimer s & Dementia. 14(7S_Part_5).
14.
Schuck, Edgar, Robert Lai, Jagadeesh Aluri, et al.. (2017). [P1–056]: POPULATION PHARMACOKINETIC‐PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS. Alzheimer s & Dementia. 13(7S_Part_5).
15.
Shumaker, Robert, et al.. (2014). Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration. The Journal of Clinical Pharmacology. 55(3). 317–327.
16.
Shumaker, Robert, Meijian Zhou, Min Ren, et al.. (2014). Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers. Cancer Chemotherapy and Pharmacology. 73(6). 1109–1117.
17.
Critchley, David, et al.. (2011). Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects. Clinical Therapeutics. 33(1). 146–157.
18.
Cox, Donna S., et al.. (2004). Pharmacokinetics and Pharmacodynamics of Argatroban in Combination With a Platelet Glycoprotein IIB/IIIA Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention. The Journal of Clinical Pharmacology. 44(9). 981–990.
19.
Aluri, Jagadeesh, et al.. (1995). Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers. Biopharmaceutics & Drug Disposition. 16(5). 381–391.
20.
Aluri, Jagadeesh & S. Stavchansky. (1993). Determination of guaifenesin in human plasma by liquid chromatography in the presence of pseudoephedrine. Journal of Pharmaceutical and Biomedical Analysis. 11(9). 803–808.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Priska Kaufmann Breakdown of academic impact, for papers by S. Erill Breakdown of academic impact, for papers by James Hilbert Breakdown of academic impact, for papers by Nancy Agrawal Breakdown of academic impact, for papers by Sarah R. Bujac Breakdown of academic impact, for papers by Peter Zannikos Breakdown of academic impact, for papers by Amanda Darekar Breakdown of academic impact, for papers by Peter Neubert Breakdown of academic impact, for papers by Patricia N. Sidharta Breakdown of academic impact, for papers by S. Leigh Verbois